Retatrutide (GLP-3)
40mg · Research grade
Retatrutide is a research-focused triple-receptor agonist analog within the incretin family, studied for metabolic-regulation pathways. Investigators use it to examine glucose homeostasis, insulin sensitivity, and appetite-related signaling in model systems. The 40mg vial supports high-volume in-vitro protocols.
$190$250Save $60
In stock · ships from the USA
1
Free US shipping on orders over $200.
$190
40mg
Research overview
Key features & characteristics
- Incretin Research Tool: Studied for activity across GLP-1, GIP, and glucagon-receptor pathways.
- Metabolic Exploration: Enables investigation of glucose homeostasis and energy metabolism.
- Characterized Compound: Synthesized to at least 99% (HPLC) with mass-spectrometry confirmation.
- Stable Form: Freeze-dried for precise reconstitution and consistent handling.
Primary research applications
- Research into incretin-receptor interactions and signaling
- Study of glucose tolerance and insulin sensitivity in models
- Investigation of appetite-regulation and nutrient metabolism
- Characterization of pharmacokinetic and pharmacodynamic profiles
Related research compounds
For research use only. Not for human or animal consumption. Products are not intended to diagnose, treat, cure, or prevent any disease and have not been evaluated by the FDA. PepNova Labs is not a compounding pharmacy or outsourcing facility as defined under sections 503A/503B of the FD&C Act.